Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
PHASE1
The purpose of this study is to test the safety of a transfusion of special...
Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant
PHASE4
The aim of this prospective, randomized study is to assess a subject's immu...
Status
Completed
Location
Hôpital Erasme- Cliniques Universitaires de Bruxelles,
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
NA
RATIONALE: Tests that measure certain changes in blood in patients at high ...